FDA Approved: SYNJARDY XR — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved SYNJARDY XR as an original application for a fixed-dose combination of empagliflozin and metformin hydrochloride (XR formulation) from Boehring…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SYNJARDY XR (Empagliflozin, Metformin hydrochloride)

Snippet

ORIG AP for SYNJARDY XR (EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE)